Shedding Light on Dry AMD with eye-light® LM™ LLLT
January 3, 2025
Explore how Espansione eye-light® might offer new hope with photobiomodulation for patients with dry age-related macular degeneration (AMD) and ocular surface disease. In this video, Prof. Giuseppe Giannaccare delves into the science behind the device’s Light Modulation™ Low-Level Light Therapy (LM LLLT), detailing its mechanism of action, the device’s journey from dry eye treatment and emerging treatment protocols for both dry eye and dry AMD. He also shares preliminary findings from the Phase 1 study and case reports that demonstrate the potential impact of LM LLLT and eye-light® on patients and practice paradigms.
Mun Xiew Foo, medical affairs director at Topcon Healthcare, also details the current landscape in dry AMD treatment—and how eye-light® technology is reshaping how clinicians think about dry AMD management.
![[Topcon] Presentation _1 Prof. Giannaccare thumbnail Shedding Light on Dry AMD with eye light® LM® LLLT (1) (1)](https://piemagazine.org/wp-content/uploads/sites/4/2025/01/Topcon-Presentation-_1-Prof.-Giannaccare-thumbnail-Shedding-Light-on-Dry-AMD-with-eye-light®-LM®-LLLT-1-1.png)
